Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05675826

The Impact of Donor COVID-19 Infection Status on the Recipient in Allo-HSCT

Conditions: COVID-19, Hematopoietic Stem Cell Transplantation

Sex: All

Ages: 16 Years – 65 Years

Enrollment: 40

Sponsor: Chen Suning

Location: China

Summary

This study was conducted to observe whether COVID-19 can be transmitted through stem cell transplantation and whether COVID-19-positive donors have an effect on early hematopoietic reconstitution and immune reconstitution in the recipients.

Eligibility Criteria

Inclusion Criteria:Age between 16 and 65 years old.History of hematological malignancies (acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas, myeloma).Allogeneic hematopoietic stem cell transplantation perform during the COVID19 pandemic.Exclusion Criteria:Hematological diseases, other than hematological malignancies.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05675826). StuddyBuddy aggregates publicly available trial information.